Feed AFIB
AF

Acutus Medical, Inc.

AFIB · OTC

$0.00 +0.00% (+$0.00)
Market Cap $2.99K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9
Valuation
84 /100
Cheap
P/S 0.00x
EV/EBITDA 9.67x
P/FFO N/A
Growth
47 /100
Stable
Rev. growth 5.30%
Book val. growth N/A
EPS growth N/A
Profitability
0 /100
Weak
Op. margin 0.28%
Gross margin 4.98%
FCF margin 157.62%
Quality
13 /100
Poor
Asset turnover 0.70x
ROIC 0.48%
ROA 33.33%
Debt
22 /100
High
Net debt/EBITDA 9.67x
Current ratio 2.06x
Int. coverage 0.21x
Stability
1 /100
Unstable
EPS volatility 104.27%
Beta 5.79x
Profitable years 0

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about AFIB
Online

About the company

Acutus Medical, Inc. is an American company focused on the development and manufacturing of advanced technologies for the treatment of cardiac arrhythmias. The company specializes in innovative technologies and imaging systems that enable physicians to better diagnose and treat cardiac arrhythmias. Their products include electrophysiological cardiac stimulation catheters and imaging systems that allow for precise mapping and navigation during procedures related to cardiac arrhythmias. Acutus Medical is known for its innovative approaches and technological innovations that help physicians provide treatment with high efficacy and safety for patients. Acutus Medical, Inc. shares could be an interesting choice for investors looking for opportunities in the treatment of cardiac diseases and healthcare technologies.

Sector

Healthcare

Industry

Medical - Devices

CEO

Takeo Mukai

Employees

85

Headquarters

Carlsbad

Upcoming events

13 NOV

Earnings

Upcoming earnings report

53d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.